{"id":51789,"date":"2022-12-09T16:02:12","date_gmt":"2022-12-09T15:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-adult-hemoglobinopathy-testing-market-to-reach-447-8-million-by-2027-researchandmarkets-com\/"},"modified":"2022-12-09T16:02:12","modified_gmt":"2022-12-09T15:02:12","slug":"global-adult-hemoglobinopathy-testing-market-to-reach-447-8-million-by-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-adult-hemoglobinopathy-testing-market-to-reach-447-8-million-by-2027-researchandmarkets-com\/","title":{"rendered":"Global Adult Hemoglobinopathy Testing Market to Reach $447.8 Million by 2027 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Adult Hemoglobinopathy Testing: Global Strategic Business Report”<\/a> has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nGlobal Adult Hemoglobinopathy Testing Market to Reach $447.8 Million by 2027<\/strong>\n<\/p>\n

\nIn the changed post COVID-19 business landscape, the global market for Adult Hemoglobinopathy Testing estimated at US$343.8 Million in the year 2020, is projected to reach a revised size of US$447.8 Million by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. HPLC Test, one of the segments analyzed in the report, is projected to record a 3.6% CAGR and reach US$276.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mass Spectrometry segment is readjusted to a revised 4% CAGR for the next 7-year period.\n<\/p>\n

\nThe U.S. Market is Estimated at $93 Million, While China is Forecast to Grow at 6.2% CAGR<\/strong>\n<\/p>\n

\nThe Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$93 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$89.5 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$58.8 Million by the year 2027.\n<\/p>\n

\nHb Electrophoresis Segment to Record 4.8% CAGR<\/strong>\n<\/p>\n

\nIn the global Hb Electrophoresis segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39 Million in the year 2020 will reach a projected size of US$53.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.2% CAGR through the analysis period.\n<\/p>\n

\nSelect Competitors (Total 44 Featured) –<\/strong>\n<\/p>\n